Sodium-Glucose Co-transporter 2 Inhibitors Versus Metformin as the First-Line Treatment for Type 2 Diabetes: Is It Time for a Revolution?
Crossref DOI link: https://doi.org/10.1007/s10557-021-07249-0
Published Online: 2021-09-03
Published Print: 2023-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Koufakis, Theocharis
Papazafiropoulou, Athanasia
Makrilakis, Konstantinos
Kotsa, Kalliopi
Text and Data Mining valid from 2021-09-03
Version of Record valid from 2021-09-03
Article History
Accepted: 23 August 2021
First Online: 3 September 2021
Declarations
:
: Not applicable.